Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

With patient safety slipping, CDC and CMS turn focus to more resilient approaches

COVID-19 has led to a quick and steep decline in patient safety across the entire American healthcare system.

HHS awards $55 million to expand virtual healthcare access

The awards will enhance telehealth, digital patient tools and health information technology to support underserved communities.

Thumbnail

Prior authorization adversely impacts patient care, workforce productivity

An AMA survey shows that prior authorization can have harsh consequences on evidence-based care that interfere with a healthy, productive workforce.

Thumbnail

CVS seeks to relieve overworked pharmacists with new policy

Pharmacists have also been affected by the pandemic, with higher than previously reported rates of burnout affecting the profession.

pain pills opioids

CDC updates clinical practice guideline for prescribing opioids

The new guideline suggests prescribing opioid-naïve patients with acute, subacute, or chronic pain the "lowest dosage to achieve expected effects."

Thumbnail

HHS warns hospitals to safeguard against LockBit 2.0 ransomware

While the cybercrime organization claims to not attack healthcare organizations it remains a threat to the entire U.S. healthcare and public health sector, according to a recent alert.

Thumbnail

More states considering legislation to help low-income patients pay high medical debt

The United States Census Bureau reports that 19% of U.S. households could not afford to pay for medical care right away.

Thumbnail

Kaiser Permanente's 'secret' Medicaid deal with California raises eyebrows

The five-year agreement would make Kaiser Permanente the only insurer with a statewide Medi-Cal contract in California.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup